The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Advances in sarcoma genomics and new therapeutic targets
Open accessAbstract
Increasingly, human mesenchymal malignancies are being classified by the abnormalities that drive their pathogenesis. Although many of these aberrations are highly prevalent within particular sarcoma subtypes, few are currently targeted therapeutically. Indeed, most subtypes of sarcoma are still treated with traditional therapeutic modalities, and in many cases sarcomas are resistant to adjuvant therapies. In this Review, we discuss the core molecular determinants of sarcomagenesis and emphasize the emerging genomic and functional genetic approaches that, coupled with novel therapeutic strategies, have the potential to transform the care of patients with sarcoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gualberto, A., Hixon, M. L., Karp, D. D., Li, D., Green, S., Dolled-Filhart, M. P., Paz-Ares, L. G., Novello, S., Blakely, J., Langer, C. J., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605972 · Cited by 85
RetractedJemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Self-citationBrocken, P., van der Heijden, H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus-Oei, L.-F. (2014) · Respiration · doi:10.1159/000347096 · Cited by 4,002
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C.-J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,301
Self-citationKinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich, M. C., Corless, C. L., Demetri, G. D., Blanke, C. D., von Mehren, M., Joensuu, H., McGreevey, L. S., Chen, C.-J., Van den Abbeele, A. D., Druker, B. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.190 · Cited by 2,299
Self-citationClinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Kantarjian, H., Shah, N. P., Hochhaus, A., Cortes, J., Shah, S., Ayala, M., Moiraghi, B., Shen, Z., Mayer, J., Pasquini, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002315 · Cited by 1,589
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460
Self-citationThe impact of translocations and gene fusions on cancer causation
Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
Bissler, J. J., McCormack, F. X., Young, L. R., Elwing, J. M., Chuck, G., Leonard, J. M., Schmithorst, V. J., Laor, T., Brody, A. S., Bean, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa063564 · Cited by 1,253
Advances in understanding cancer genomes through second-generation sequencing
Meyerson, M., Gabriel, S., & Getz, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2841 · Cited by 1,116
Disrupting the Pairing Between let-7 and Hmga2 Enhances Oncogenic Transformation
Mayr, C., Hemann, M. T., & Bartel, D. P. (2007) · Science · doi:10.1126/science.1137999 · Cited by 1,100
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
Pao, W., & Chmielecki, J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2947 · Cited by 1,083
Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J. C., Huang, J. H., Alexander, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710052104 · Cited by 1,075
Self-citationAmary, M. F., Bacsi, K., Maggiani, F., Damato, S., Halai, D., Berisha, F., Pollock, R., O'Donnell, P., Grigoriadis, A., Diss, T., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2913 · Cited by 1,023
Essential role for nuclear PTEN in maintaining chromosomal integrity
Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979
Soft-Tissue Sarcomas in Adults
Clark, M. A., Fisher, C., Judson, I., & Thomas, J. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041866 · Cited by 907
Transcriptome sequencing to detect gene fusions in cancer
Maher, C. A., Kumar-Sinha, C., Cao, X., Kalyana-Sundaram, S., Han, B., Jing, X., Sam, L., Barrette, T., Palanisamy, N., & Chinnaiyan, A. M. (2009) · Nature · doi:10.1038/nature07638 · Cited by 900
Forcing cells to change lineages
Graf, T., & Enver, T. (2009) · Nature · doi:10.1038/nature08533 · Cited by 899
Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
Butrynski, J. E., D'Adamo, D. R., Hornick, J. L., Dal Cin, P., Antonescu, C. R., Jhanwar, S. C., Ladanyi, M., Capelletti, M., Rodig, S. J., Ramaiya, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007056 · Cited by 870
Self-citationShen, R., Olshen, A. B., & Ladanyi, M. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp543 · Cited by 849
Self-citationAntonescu, C. R., Besmer, P., Guo, T., Arkun, K., Hom, G., Koryotowski, B., Leversha, M. A., Jeffrey, P. D., Desantis, D., Singer, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2245 · Cited by 836
Self-citationMolecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Blanke, C. D., Demetri, G. D., Joensuu, H., Roberts, P. J., Eisenberg, B. L., von Mehren, M., Fletcher, C. D. M., Sandau, K., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2265 · Cited by 814
Nuclear reprogramming to a pluripotent state by three approaches
Yamanaka, S., & Blau, H. M. (2010) · Nature · doi:10.1038/nature09229 · Cited by 776
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Barretina, J., Taylor, B. S., Banerji, S., Ramos, A. H., Lagos-Quintana, M., DeCarolis, P. L., Shah, K., Socci, N. D., Weir, B. A., Ho, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.619 · Cited by 735
Self-citationDenosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
Thomas, D., Henshaw, R., Skubitz, K., Chawla, S., Staddon, A., Blay, J.-Y., Roudier, M., Smith, J., Ye, Z., Sohn, W., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70010-3 · Cited by 716
Signatures of mutation and selection in the cancer genome
Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707
Sleijfer, S., Ray-Coquard, I., Papai, Z., Le Cesne, A., Scurr, M., Schöffski, P., Collin, F., Pandite, L., Marreaud, S., De Brauwer, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3223 · Cited by 679
Targeting the cancer kinome through polypharmacology
Knight, Z. A., Lin, H., & Shokat, K. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2787 · Cited by 674 · cited 1×
“Other approaches warrant study, including polypharmacology (the simultaneous inhibition of multiple targets”
Clinical assessment incorporating a personal genome
Ashley, E. A., Butte, A. J., Wheeler, M. T., Chen, R., Klein, T. E., Dewey, F. E., Dudley, J. T., Ormond, K. E., Pavlovic, A., Morgan, A. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60452-7 · Cited by 674
Soft tissue sarcomas of adults: state of the translational science.
Borden, E. C., Baker, L. H., Bell, R. S., Bramwell, V. H. C., Demetri, G. D., Eisenberg, B. L., Fletcher, C. D. �., Fletcher, J. A., Ladanyi, M., Meltzer, P. S., et al. (2003) · PubMed · Cited by 612
Self-citationAndrogen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
Haffner, M. C., Aryee, M. J., Toubaji, A., Esopi, D. M., Albadine, R., Gurel, B., Isaacs, W. B., Bova, G. S., Liu, W., Xu, J., et al. (2010) · Nature Genetics · doi:10.1038/ng.613 · Cited by 608
The NF1 tumor suppressor critically regulates TSC2 and mTOR
Johannessen, C. M., Reczek, E. E., James, M. F., Brems, H., Legius, E., & Cichowski, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503224102 · Cited by 601
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
Sharma, S. V., Haber, D. A., & Settleman, J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2820 · Cited by 586
Lin, C., Yang, L., Tanasa, B., Hutt, K., Ju, B.-G., Ohgi, K. A., Zhang, J., Rose, D. W., Fu, X.-D., Glass, C. K., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.030 · Cited by 576
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Maki, R. G., D'Adamo, D. R., Keohan, M. L., Saulle, M., Schuetze, S. M., Undevia, S. D., Livingston, M. B., Cooney, M. M., Hensley, M. L., Mita, M. M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4495 · Cited by 569
Self-citationShen, R., Olshen, A. B., & Ladanyi, M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp659 · Cited by 566
Self-citationErrani, C., Zhang, L., Sung, Y. S., Hajdu, M., Singer, S., Maki, R. G., Healey, J. H., & Antonescu, C. R. (2011) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20886 · Cited by 553
Self-citationPathology and genetics of tumors of soft tissue and bone
Fletcher, C. D. �. (2002) · Medical Entomology and Zoology · Cited by 550
Highly parallel identification of essential genes in cancer cells
Luo, B., Cheung, H. W., Subramanian, A., Sharifnia, T., Okamoto, M., Yang, X., Hinkle, G., Boehm, J. S., Beroukhim, R., Weir, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810485105 · Cited by 547
Mesenchymal Stem Cell Features of Ewing Tumors
Tirode, F., Laud-Duval, K., Prieur, A., Delorme, B., Charbord, P., & Delattre, O. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.027 · Cited by 507
Pasini, B., McWhinney, S. R., Bei, T., Matyakhina, L., Stergiopoulos, S., Muchow, M., Boikos, S. A., Ferrando, B., Pacak, K., Assie, G., et al. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201904 · Cited by 487
An integrated approach to uncover drivers of cancer
Akavia, U. D., Litvin, O., Kim, J., Sanchez-Garcia, F., Kotliar, D., Causton, H. C., Pochanard, P., Mozes, E., Garraway, L. A., & Pe'er, D. (2010) · Cell · doi:10.1016/j.cell.2010.11.013 · Cited by 484
Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4
Stepanova, L., Leng, X., Parker, S. B., & Harper, J. W. (1996) · Genes & Development · doi:10.1101/gad.10.12.1491 · Cited by 483 · cited 1×
“One such example is an inhibitor of cell division cycle 37 (CDC37), a protein that links KIT to the chaperone heat shock protein 90 (HSP90); this inhibitor may potentiate KIT degradation without the potential toxicity that is inherent to inhibiting too many HSP90 client protein”
McArthur, G. A., Demetri, G. D., van Oosterom, A., Heinrich, M. C., Debiec-Rychter, M., Corless, C. L., Nikolova, Z., Dimitrijevic, S., & Fletcher, J. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.088 · Cited by 482
Chibon, F., Lagarde, P., Salas, S., Pérot, G., Brouste, V., Tirode, F., Lucchesi, C., de Reynies, A., Kauffmann, A., Bui, B., et al. (2010) · Nature Medicine · doi:10.1038/nm.2174 · Cited by 474
Mechanisms of sarcoma development
Helman, L. J., & Meltzer, P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1168 · Cited by 460
Erkizan, H. V., Kong, Y., Merchant, M., Schlottmann, S., Barber-Rotenberg, J. S., Yuan, L., Abaan, O. D., Chou, T.-H., Dakshanamurthy, S., Brown, M. L., et al. (2009) · Nature Medicine · doi:10.1038/nm.1983 · Cited by 452
An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer
Zender, L., Xue, W., Zuber, J., Semighini, C. P., Krasnitz, A., Ma, B., Zender, P., Kubicka, S., Luk, J. M., Schirmacher, P., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.061 · Cited by 428
Prieur, A., Tirode, F., Cohen, P., & Delattre, O. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7275-7283.2004 · Cited by 420
Wagner, A. J., Malinowska-Kolodziej, I., Morgan, J. A., Qin, W., Fletcher, C. D. M., Vena, N., Ligon, A. H., Antonescu, C. R., Ramaiya, N. H., Demetri, G. D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.2981 · Cited by 399
Self-citationInduced Chromosomal Proximity and Gene Fusions in Prostate Cancer
Mani, R.-S., Tomlins, S. A., Callahan, K., Ghosh, A., Nyati, M. K., Varambally, S., Palanisamy, N., & Chinnaiyan, A. M. (2009) · Science · doi:10.1126/science.1178124 · Cited by 391
Agulnik, M., Yarber, J. L., Okuno, S. H., von Mehren, M., Jovanovic, B. D., Brockstein, B. E., Evens, A. M., & Benjamin, R. S. (2013) · Annals of Oncology · doi:10.1093/annonc/mds237 · Cited by 389
Novel V600E BRAF mutations in imatinib‐naive and imatinib‐resistant gastrointestinal stromal tumors
Agaram, N. P., Wong, G. C., Guo, T., Maki, R. G., Singer, S., DeMatteo, R. P., Besmer, P., & Antonescu, C. R. (2008) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20589 · Cited by 388
Self-citationSirvent, N., Coindre, J.-M., Maire, G., Hostein, I., Keslair, F., Guillou, L., Ranchere-Vince, D., Terrier, P., & Pedeutour, F. (2007) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3180581fff · Cited by 374
Lineage dependency and lineage-survival oncogenes in human cancer
Garraway, L. A., & Sellers, W. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1947 · Cited by 360
Hahm, K.-B., Cho, K., Lee, C., Im, Y.-H., Chang, J., Choi, S.-G., Sorensen, P. H. B., Thiele, C. J., & Kim, S.-J. (1999) · Nature Genetics · doi:10.1038/13854 · Cited by 348
Wang, L., Motoi, T., Khanin, R., Olshen, A., Mertens, F., Bridge, J., Cin, P. D., Antonescu, C. R., Singer, S., Hameed, M., et al. (2012) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20937 · Cited by 347
Self-citationOlmos, D., Postel-Vinay, S., Molife, L. R., Okuno, S. H., Schuetze, S. M., Paccagnella, M. L., Batzel, G. N., Yin, D., Pritchard-Jones, K., Judson, I., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70354-7 · Cited by 340
Chimeric transcript discovery by paired-end transcriptome sequencing
Maher, C. A., Palanisamy, N., Brenner, J. C., Cao, X., Kalyana-Sundaram, S., Luo, S., Khrebtukova, I., Barrette, T. R., Grasso, C., Yu, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904720106 · Cited by 339
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours
Chi, P., Chen, Y., Zhang, L., Guo, X., Wongvipat, J., Shamu, T., Fletcher, J. A., Dewell, S., Maki, R. G., Zheng, D., et al. (2010) · Nature · doi:10.1038/nature09409 · Cited by 336
Self-citationRiggi, N., Suvà, M.-L., Suvà, D., Cironi, L., Provero, P., Tercier, S., Joseph, J.-M., Stehle, J.-C., Baumer, K., Kindler, V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1761 · Cited by 332
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin
Haldar, M., Hancock, J. D., Coffin, C. M., Lessnick, S. L., & Capecchi, M. R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.016 · Cited by 326
Pappo, A. S., Patel, S. R., Crowley, J., Reinke, D. K., Kuenkele, K.-P., Chawla, S. P., Toner, G. C., Maki, R. G., Meyers, P. A., Chugh, R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.0000 · Cited by 322
Self-citationTolcher, A. W., Sarantopoulos, J., Patnaik, A., Papadopoulos, K., Lin, C.-C., Rodon, J., Murphy, B., Roth, B., McCaffery, I., Gorski, K. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6745 · Cited by 308
Tsuda, M., Davis, I. J., Argani, P., Shukla, N., McGill, G. G., Nagai, M., Saito, T., Laé, M., Fisher, D. E., & Ladanyi, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2855 · Cited by 306
Self-citationRichter, G. H. S., Plehm, S., Fasan, A., Rössler, S., Unland, R., Bennani-Baiti, I. M., Hotfilder, M., Löwel, D., von Luettichau, I., Mossbrugger, I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810759106 · Cited by 305
Keller, C., Arenkiel, B. R., Coffin, C. M., El-Bardeesy, N., DePinho, R. A., & Capecchi, M. R. (2004) · Genes & Development · doi:10.1101/gad.1244004 · Cited by 304
A spatially and temporally restricted mouse model of soft tissue sarcoma
Kirsch, D. G., Dinulescu, D. M., Miller, J. B., Grimm, J., Santiago, P. M., Young, N. P., Nielsen, G. P., Quade, B. J., Chaber, C. J., Schultz, C. P., et al. (2007) · Nature Medicine · doi:10.1038/nm1602 · Cited by 301
Microsatellites as EWS/FLI response elements in Ewing's sarcoma
Gangwal, K., Sankar, S., Hollenhorst, P. C., Kinsey, M., Haroldsen, S. C., Shah, A. A., Boucher, K. M., Watkins, W. S., Jorde, L. B., Graves, B. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801073105 · Cited by 297 · cited 1×
“The numbers of bound genomic regions in such studies have varied widel”
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
Hernando, E., Charytonowicz, E., Dudas, M. E., Menendez, S., Matushansky, I., Mills, J., Socci, N. D., Behrendt, N., Ma, L., Maki, R. G., et al. (2007) · Nature Medicine · doi:10.1038/nm1560 · Cited by 291
Self-citationCutforth, T. (1994) · Cell · doi:10.1016/0092-8674(94)90442-1 · Cited by 287
Cooperative Epigenetic Modulation by Cancer Amplicon Genes
Rui, L., Emre, N. C. T., Kruhlak, M. J., Chung, H.-J., Steidl, C., Slack, G., Wright, G. W., Lenz, G., Ngo, V. N., Shaffer, A. L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.013 · Cited by 283
Riggi, N., Suvà, M.-L., De Vito, C., Provero, P., Stehle, J.-C., Baumer, K., Cironi, L., Janiszewska, M., Petricevic, T., Suvà, D., et al. (2010) · Genes & Development · doi:10.1101/gad.1899710 · Cited by 279
Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors
Pedeutour, F., Forus, A., Coindre, J.-M., Berner, J.-M., Nicolo, G., Michiels, J.-F., Terrier, P., Ranchere-Vince, D., Collin, F., Myklebost, O., et al. (1999) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199901)24:1<30::aid-gcc5>3.0.co;2-p · Cited by 274
KDR Activating Mutations in Human Angiosarcomas Are Sensitive to Specific Kinase Inhibitors
Antonescu, C. R., Yoshida, A., Guo, T., Chang, N.-E., Zhang, L., Agaram, N. P., Qin, L.-X., Brennan, M. F., Singer, S., & Maki, R. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2068 · Cited by 274
Self-citationPreclinical model of organotypic culture for pharmacodynamic profiling of human tumors
Vaira, V., Fedele, G., Pyne, S., Fasoli, E., Zadra, G., Bailey, D., Snyder, E., Faversani, A., Coggi, G., Flavin, R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907676107 · Cited by 267
Lessnick, S. L., Dacwag, C. S., & Golub, T. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00056-9 · Cited by 264
Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
Gounder, M. M., Lefkowitz, R. A., Keohan, M. L., D'Adamo, D. R., Hameed, M., Antonescu, C. R., Singer, S., Stout, K., Ahn, L., & Maki, R. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3322 · Cited by 255
Self-citationMaki, R. G., Awan, R. A., Dixon, R. H., Jhanwar, S., & Antonescu, C. R. (2002) · International Journal of Cancer · doi:10.1002/ijc.10535 · Cited by 250
Self-citationSinger, S., Socci, N. D., Ambrosini, G., Sambol, E., Decarolis, P., Wu, Y., O'Connor, R., Maki, R., Viale, A., Sander, C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0584 · Cited by 250
Self-citationHuang, H.-Y., Illei, P. B., Zhao, Z., Mazumdar, M., Huvos, A. G., Healey, J. H., Wexler, L. H., Gorlick, R., Meyers, P., & Ladanyi, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.081 · Cited by 248
Self-citationSommer, G., Agosti, V., Ehlers, I., Rossi, F., Corbacioglu, S., Farkas, J., Moore, M., Manova, K., Antonescu, C. R., & Besmer, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1037763100 · Cited by 244
Self-citationCao, L., Yu, Y., Bilke, S., Walker, R. L., Mayeenuddin, L. H., Azorsa, D. O., Yang, F., Pineda, M., Helman, L. J., & Meltzer, P. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0582 · Cited by 239
Scotlandi, K., Benini, S., Sarti, M., Serra, M., Lollini, P., Maurici, D., Picci, P., Manara, M. C., & Baldini, N. (1996) · PubMed · Cited by 227
Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors
Gramza, A. W., Corless, C. L., & Heinrich, M. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0190 · Cited by 226
El-Rifai, W. M., Sarlomo‐Rikala, M., Andersson, L. C., Knuutila, S., & Miettinen, M. (2000) · PubMed · Cited by 224
Guillon, N., Tirode, F., Boeva, V., Zynovyev, A., Barillot, E., & Delattre, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004932 · Cited by 218
Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer
Maki, R. G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5040 · Cited by 218
Self-citationMolecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients
Maertens, O., Prenen, H., Debiec-Rychter, M., Wozniak, A., Sciot, R., Pauwels, P., De Wever, I., Vermeesch, J. R., de Raedt, T., De Paepe, A., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl016 · Cited by 214
Mariani, O., Brennetot, C., Coindre, J.-M., Gruel, N., Ganem, C., Delattre, O., Stern, M.-H., & Aurias, A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.007 · Cited by 211
Synovial Sarcoma Is a Stem Cell Malignancy
Naka, N., Takenaka, S., Araki, N., Miwa, T., Hashimoto, N., Yoshioka, K., Joyama, S., Hamada, K.-I., Tsukamoto, Y., Tomita, Y., et al. (2010) · Stem Cells · doi:10.1002/stem.452 · Cited by 205
Oncogenic MITF dysregulation in clear cell sarcoma: Defining the MiT family of human cancers
Davis, I. J., Kim, J. J., Ozsolak, F., Widlund, H. R., Rozenblatt-Rosen, O., Granter, S. R., Du, J., Fletcher, J. A., Denny, C. T., Lessnick, S. L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.021 · Cited by 202
Kurzrock, R., Patnaik, A., Aisner, J., Warren, T., Leong, S., Benjamin, R., Eckhardt, S. G., Eid, J. E., Greig, G., Habben, K., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3220 · Cited by 196
A Molecular Function Map of Ewing's Sarcoma
Kauer, M., Ban, J., Kofler, R., Walker, B., Davis, S., Meltzer, P., & Kovar, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005415 · Cited by 191
A complex task? Direct modulation of transcription factors with small molecules
Koehler, A. N. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.022 · Cited by 189
Hu-Lieskovan, S., Zhang, J., Wu, L., Shimada, H., Schofield, D. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2857 · Cited by 186
c-Met Expression Is Regulated by Mitf in the Melanocyte Lineage
McGill, G. G., Haq, R., Nishimura, E. K., & Fisher, D. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513094200 · Cited by 174
Drugs for ‘protein clouds’: targeting intrinsically disordered transcription factors
Dunker, A. K., & Uversky, V. N. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.09.005 · Cited by 174
Janeway, K. A., Liegl, B., Harlow, A., Le, C., Perez-Atayde, A., Kozakewich, H., Corless, C. L., Heinrich, M. C., & Fletcher, J. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1938 · Cited by 173
Park, M. S., Ravi, V., & Araujo, D. M. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32833aaad4 · Cited by 172
Inhibition of ALK Signaling for Cancer Therapy
Mossé, Y. P., Wood, A., & Maris, J. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2762 · Cited by 172
Functional Copy-Number Alterations in Cancer
Taylor, B. S., Barretina, J., Socci, N. D., DeCarolis, P., Ladanyi, M., Meyerson, M., Singer, S., & Sander, C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003179 · Cited by 170
Self-citationGLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
Beauchamp, E., Bulut, G., Abaan, O., Chen, K., Merchant, A., Matsui, W., Endo, Y., Rubin, J. S., Toretsky, J., & Üren, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806233200 · Cited by 170
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
Forni, C., Minuzzo, M., Virdis, E., Tamborini, E., Simone, M., Tavecchio, M., Erba, E., Grosso, F., Gronchi, A., Aman, P., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0848 · Cited by 169
Huang, F., Greer, A., Hurlburt, W., Han, X., Hafezi, R., Wittenberg, G. M., Reeves, K., Chen, J., Robinson, D., Li, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0835 · Cited by 164
Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressorPreprint
Cichowski, K. M., Santiago, S., Jardim, M. J., Johnson, B. W., & Jacks, T. (2003) · Genes & Development · doi:10.1101/gad.1054703 · Cited by 163
Quek, R., Wang, Q., Morgan, J. A., Shapiro, G. I., Butrynski, J. E., Ramaiya, N., Huftalen, T., Jederlinic, N., Manola, J., Wagner, A. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2621 · Cited by 162
Bric, A., Miething, C., Bialucha, C. U., Scuoppo, C., Zender, L., Krasnitz, A., Xuan, Z., Zuber, J., Wigler, M., Hicks, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.015 · Cited by 161
Blay, J.-Y., El Sayadi, H., Thiesse, P., Garret, J., & Ray-Coquard, I. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn033 · Cited by 158
Validation of Met as a Therapeutic Target in Alveolar and Embryonal Rhabdomyosarcoma
Taulli, R., Scuoppo, C., Bersani, F., Accornero, P., Forni, P. E., Miretti, S., Grinza, A., Allegra, P., Schmitt-Ney, M., Crepaldi, T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4292 · Cited by 155
Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences
Mani, R. S., & Chinnaiyan, A. M. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2883 · Cited by 153
Riggi, N., Cironi, L., Provero, P., Suvà, M.-L., Stehle, J., Baumer, K., Guillou, L., & Stamenkovic, I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3979 · Cited by 152
Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling
Beck, A. H., Lee, C.-H., Witten, D., Gleason, B., Edris, B., Espinosa, Í., Zhu, S., Li, R., Montgomery, K. D., Marinelli, R. J., et al. (2009) · Oncogene · doi:10.1038/onc.2009.381 · Cited by 150
The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice
Pérez‐Losada, J., Pintado, B., Gutiérrez‐Adán, A., Flores, T., Bañares-González, B., del Campo, J. C., Martín-Martín, J. F., Battaner, E., & Sánchez-García, I. (2000) · Oncogene · doi:10.1038/sj.onc.1203572 · Cited by 149
A Knock-In Mouse Model of Gastrointestinal Stromal Tumor Harboring Kit K641E
Rubin, B. P., Antonescu, C. R., Scott-Browne, J. P., Comstock, M., Gu, Y., Tanas, M. R., Ware, C. B., & Woodell, J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0891 · Cited by 148
Self-citationResponse to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma
Stacchiotti, S., Tamborini, E., Marrari, A., Brich, S., Rota, S. A., Orsenigo, M., Crippa, F., Morosi, C., Gronchi, A., Pierotti, M. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2050 · Cited by 145
Gibault, L., Pérot, G., Chibon, F., Bonnin, S., Lagarde, P., Terrier, P., Coindre, J., & Aurias, A. (2010) · The Journal of Pathology · doi:10.1002/path.2787 · Cited by 141
The EWS/FLI1 oncogenic transcription factor deregulates GLI1
Zwerner, J. P., Joo, J., Warner, K., Christensen, L., Hu‐Lieskovan, S., Triche, T. J., & May, W. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210991 · Cited by 135
The GIST paradigm: lessons for other kinase‐driven cancers
Antonescu, C. R. (2010) · The Journal of Pathology · doi:10.1002/path.2798 · Cited by 133
Self-citationGene amplifications in osteosarcoma—CGH microarray analysis
Atiye, J., Wolf, M., Kaur, S., Monni, O. M., Böhling, T., Kivioja, A., Tas, É., Serra, M., Tarkkanen, M., & Knuutila, S. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20120 · Cited by 130
A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development
Post, S. M., Quintás-Cardama, A., Pant, V., Iwakuma, T., Hamir, A., Jackson, J. G., Maccio, D. R., Bond, G. L., Johnson, D. G., Levine, A. J., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.07.010 · Cited by 127
Subramanian, S., Thayanithy, V., West, R. B., Lee, C., Beck, A. H., Zhu, S., Downs-Kelly, E. P., Montgomery, K. D., Goldblum, J. R., Hogendoorn, P. C. W., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2633 · Cited by 126
Meacham, C. E., Ho, E. E., Dubrovsky, E., Gertler, F. B., & Hemann, M. T. (2009) · Nature Genetics · doi:10.1038/ng.451 · Cited by 126
p16INK4a Prevents Centrosome Dysfunction and Genomic Instability in Primary Cells
McDermott, K. M., Zhang, J., Holst, C. R., Kozakiewicz, B. K., Singla, V., & Tlsty, T. D. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040051 · Cited by 125
Herrero‐Martín, D., Osuna, D., Ordóñez, J. L., Sevillano, V., Martins, A. S., Mackintosh, C., Campos, M., Madoz‐Gúrpide, J., Otero-Motta, A. P., Caballero, G., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605104 · Cited by 124
PTEN dosage is essential for neurofibroma development and malignant transformation
Gregorian, C., Nakashima, J. K., Dry, S., Nghiemphu, P. L., Smith, K. B., Ao, Y., Dang, J. H. T., Lawson, G. W., Mellinghoff, I. K., Mischel, P. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910398106 · Cited by 122
Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A
Müller, C. R., Paulsen, E. B., Noordhuis, P., Pedeutour, F., Sæter, G., & Myklebost, O. (2007) · International Journal of Cancer · doi:10.1002/ijc.22643 · Cited by 119
Möller, E., Stenman, G., Mandahl, N., Hamberg, H., Mölne, L., van den Oord, J., Brosjö, O., Mertens, F., & Panagopoulos, I. (2008) · The Journal of Pathology · doi:10.1002/path.2327 · Cited by 119
IGF1 Is a Common Target Gene of Ewing's Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells
Cironi, L., Riggi, N., Provero, P., Wolf, N., Suvà, M.-L., Suvà, D., Kindler, V., & Stamenkovic, I. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002634 · Cited by 118
Davis, I. J., McFadden, A. W., Zhang, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1121 · Cited by 118
Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells.
Torchia, E. C., Jaishankar, S., & Baker, S. J. (2003) · PubMed · Cited by 116
Ito, M., Barys, L., O'Reilly, T., Young, S., Gorbatcheva, B., Monahan, J., Zumstein-Mecker, S., Choong, P. F., Dickinson, I., Crowe, P., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2050 · Cited by 115
Mesenchymal Stem Cells and the Origin of Ewing's Sarcoma
Lin, P. P., Wang, Y., & Lozano, G. (2010) · Sarcoma · doi:10.1155/2011/276463 · Cited by 114
EWS-FLI1 Suppresses NOTCH-Activated p53 in Ewing's Sarcoma
Ban, J., Bennani-Baı̈ti, I. M., Kauer, M., Schaefer, K., Poremba, C., Jug, G., Schwentner, R., Smrzka, O. W., Muehlbacher, K., Aryee, D. N. T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6145 · Cited by 112
Hélias‐Rodzewicz, Z., Pérot, G., Chibon, F., Ferreira, C., Lagarde, P., Terrier, P., Coindre, J., & Aurias, A. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20825 · Cited by 110
Constant p53 Pathway Inactivation in a Large Series of Soft Tissue Sarcomas with Complex Genetics
Pérot, G., Chibon, F., Montero, A., Lagarde, P., de Thé, H., Terrier, P., Guillou, L., Ranchère‐Vince, D., Coindre, J., & Aurias, A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100104 · Cited by 110
EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12)
Yamaguchi, S., Yamazaki, Y., Ishikawa, Y., Kawaguchi, N., Mukai, H., & Nakamura, T. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20171 · Cited by 109
Ren, Y.-X., Finckenstein, F. G., Abdueva, D. A., Shahbazian, V. L., Chung, B., Weinberg, K. I., Triche, T. J., Shimada, H., & Anderson, M. J. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0859 · Cited by 108
Im, Y. H., Kim, H. T., Lee, C., Poulin, D., Welford, S. M., Sorensen, P. H., Denny, C. T., & Kim, S. (2000) · PubMed · Cited by 104
Meza‐Zepeda, L. A., Kresse, S. H., Barragan-Polania, A. H., Bjerkehagen, B., Ohnstad, H. O., Namløs, H. M., Wang, J., Kristiansen, B., & Myklebost, O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1972 · Cited by 103
Ginsberg, J. P., Davis, R. J., Bennicelli, J. L., Nauta, L. E., & Barr, F. G. (1998) · PubMed · Cited by 103
Ulaner, G. A., Hoffman, A. R., Otero, J. E., Huang, H., Zhao, Z., Mazumdar, M., Gorlick, R. G., Meyers, P. A., Healey, J. H., & Ladanyi, M. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20074 · Cited by 102
Self-citationTranslocations, cancer and the puzzle of specificity
Barr, F. G. (1998) · Nature Genetics · doi:10.1038/475 · Cited by 97
Idbaïh, A., Coindre, J., Derré, J., Mariani, O., Terrier, P., Ranchère‐Vince, D., Mairal, A., & Aurias, A. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700202 · Cited by 94
van Beerendonk, H. M., Rozeman, L. B., Taminiau, A. H. M., Sciot, R., Bovée, J. V. M. G., Cleton-Jansen, A., & Hogendoorn, P. C. W. (2004) · The Journal of Pathology · doi:10.1002/path.1517 · Cited by 92
Clinicopathologic Features of Osteosarcoma in Patients With Rothmund-Thomson Syndrome
Hicks, J. M., Roth, J. R., Kozinetz, C. A., & Wang, L. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.4558 · Cited by 92
Guo, T., Hajdu, M., Agaram, N. P., Shinoda, H., Veach, D. R., Clarkson, B. D., Maki, R. G., Singer, S., DeMatteo, R. P., Besmer, P., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1315 · Cited by 91
Self-citationMacarulla, T. M., Cervantes, A. M. R., Élez, E., Rodríguez-Braun, E., Baselga, J. M., Roselló, S., Sala, G., Blasco, I., Danaee, H., Lee, Y., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0299 · Cited by 90
Mercado, G., & Barr, F. G. (2007) · Current Molecular Medicine · doi:10.2174/156652407779940440 · Cited by 89
Snyder, E. L., Sandstrom, D. J., Law, K., Fiore, C., Sicińska, E., Brito, J. M., Bailey, D., Fletcher, J. A., Loda, M. F., Rodig, S. J., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2564 · Cited by 89
Peng, T., Zhang, P., Liu, J., Nguyen, T. P. T., Bolshakov, S. V., Belousov, R., Young, E. D., Wang, X., Savannah, K. J. B., López-Terrada, D., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.185 · Cited by 87
Lafferty‐Whyte, K., Cairney, C. J., Will, M., Serakıncı, N., Daidone, M. G., Zaffaroni, N., Bilsland, A. E., & Keith, W. N. (2009) · Oncogene · doi:10.1038/onc.2009.238 · Cited by 82
Pérot, G., Derré, J., Coindre, J., Tirode, F., Lucchesi, C., Mariani, O., Gibault, L., Guillou, L., Terrier, P., & Aurias, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1443 · Cited by 79
Translocation-Related Sarcomas
Mertens, F., Antonescu, C. R., Hohenberger, P., Ladanyi, M., Modena, P., D’Incalci, M., Casali, P. G., Aglietta, M., & Alvegård, T. A. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.06.004 · Cited by 77
Self-citationGöransson, M., Andersson, M. K., Forni, C., Ståhlberg, A., Andersson, C. X., Olofsson, A., Mantovani, R., & Åman, P. (2008) · Oncogene · doi:10.1038/onc.2008.378 · Cited by 75
Boeva, V., Surdez, D., Guillon, N., Tirode, F., Fejes, A. P., Delattre, O., & Barillot, E. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq217 · Cited by 75
Werner, S. R., Prahalad, A. K., Yang, J., & Hock, J. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.093 · Cited by 74
Hahm, K. (1999) · Nature Genetics · doi:10.1038/70611 · Cited by 74
Downstream EWS/FLI1 - upstream Ewing's sarcoma
Kovar, H. (2010) · Genome Medicine · doi:10.1186/gm129 · Cited by 73
Mercado, G., Xia, S. J., Zhang, C., Ahn, E. H., Gustafson, D. M., Lae, M. E., Ladanyi, M., & Barr, F. G. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20554 · Cited by 71
Self-citationHorvai, A., DeVries, S., Roy, R., O’Donnell, R. J., & Waldman, F. M. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.119 · Cited by 69
Potratz, J. C., Saunders, D. N., Wai, D., Ng, T., McKinney, S. E., Carboni, J. M., Gottardis, M. M., Triche, T. J., Jürgens, H., Pollak, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1093 · Cited by 69
Targeting CDC37: An alternative, kinase-directed strategy for disruption of oncogenic chaperoning
Smith, J. R., & Workman, P. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7531 · Cited by 67
Chibon, F., Mariani, O., Derré, J., Mairal, A., Coindre, J., Guillou, L., Sastre‐Garau, X., Pédeutour, F., & Aurias, A. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20012 · Cited by 66
Towards patient-based cancer therapeutics
The Cancer Target Discovery and Development Network, Schreiber, S. L., Shamji, A. F., Clemons, P. A., Hon, C., Koehler, A. N., Muñoz, B., Palmer, M. A. J., Stern, A. M., Wagner, B. K., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt0910-904 · Cited by 66
Frequent amplifications and abundant expression ofTRIO,NKD2, andIRX2 in soft tissue sarcomas
Adamowicz, M. J., Radlwimmer, B., Rieker, R. J., Mertens, D., Schwarzbach, M., Schraml, P., Benner, A., Lichter, P., Mechtersheimer, G., & Joos, S. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20343 · Cited by 61
Heidenblad, M., Hallor, K. H., Staaf, J., Jönsson, G. B., Borg, Å., Höglund, M., Mertens, F., & Mandahl, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209693 · Cited by 53
Martı́nez, N., Sánchez‐Beato, M., Carnero, A., Moneo, V., Tercero, J. C., Fernández, I., Navarrete, M., Jimeno, J. M., & Piris, M. A. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0316 · Cited by 52
Animal models of soft-tissue sarcoma
Dodd, R. D., Mito, J., & Kirsch, D. G. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005223 · Cited by 52
Development of IGF-IR inhibitors in pediatric sarcomas
Kolb, E. A., & Gorlick, R. G. (2009) · Current Oncology Reports · doi:10.1007/s11912-009-0043-1 · Cited by 51
Navarro, D., Agrá, N., Pestaña, Á., Alonso, J., & González‐Sancho, J. M. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp317 · Cited by 48
The Ewing's sarcoma fusion protein, EWS‐FLI, binds Runx2 and blocks osteoblast differentiation
Li, X., McGee‐Lawrence, M. E., Decker, M., & Westendorf, J. J. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22782 · Cited by 46
A CreER-Based Random Induction Strategy for Modeling Translocation-Associated Sarcomas in Mice
Haldar, M., Hedberg, M. L., Hockin, M. F., & Capecchi, M. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4127 · Cited by 45
Selective Effects of the Anticancer Drug Yondelis (ET-743) on Cell-Cycle Promoters
Minuzzo, M., Ceribelli, M., Pitarque, M., Borrelli, S., Erba, E., diSilvio, A., D’Incalci, M., & Mantovani, R. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013615 · Cited by 45
Sirolimus Treatment for Pulmonary Lymphangioleiomyomatosis
Taillé, C., Debray, M., & Crestani, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00022 · Cited by 42
On the Contribution of Spatial Genome Organization to Cancerous Chromosome Translocations
Soutoglou, E., & Misteli, T. (2008) · JNCI Monographs · doi:10.1093/jncimonographs/lgn017 · Cited by 40
Genomic characteristics of soft tissue sarcomas
Mertens, F., Panagopoulos, I., & Mandahl, N. (2009) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-009-0736-8 · Cited by 38
Hélias‐Rodzewicz, Z., Pédeutour, F., Coindre, J., Terrier, P., & Aurias, A. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20696 · Cited by 34
Correction: Delayed early embryonic lethality following disruption of the murine cyclin A2 gene
Murphy, M. (1999) · Nature Genetics · doi:10.1038/70612 · Cited by 34
Goldberg, J., Demetri, G. D., Choy, E., Rosen, L. S., Pappo, A. S., DuBois, S. G., Geller, J. I., Chai, F., Ferrari, D., & Wagner, A. J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.10502 · Cited by 32
Willems, S. M., Schrage, Y. M., Bruijn, I. H. B., Szuhai, K., Hogendoorn, P. C. W., & Bovée, J. V. M. G. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-257 · Cited by 30
Frapolli, R., Tamborini, E., Virdis, E., Bello, E., Tarantino, E., Marchini, S., Grosso, F., Sanfilippo, R. G., Gronchi, A., Tercero, J. C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0317 · Cited by 28
Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma
Ohali, A., Avigad, S., Naumov, I., Goshen, Y., Ash, S., & Yaniv, I. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20600 · Cited by 20
Martínez-Serra, J., Maffiotte, E., Martín‐Broto, J., Bex, T., Navarro-Palou, M., Ros, T., Plazas, J. M., Vögler, O., Gutierrez, A. M., Amat, J. C., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.02.035 · Cited by 20
Novo, F. J., & Vizmanos, J. L. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.02.001 · Cited by 17
Function of EWS-POU5F1 in Sarcomagenesis and Tumor Cell Maintenance
Fujino, T., Nomura, K., Ishikawa, Y., Makino, H., Umezawa, A., Aburatani, H., Nagasaki, K., & Nakamura, T. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090486 · Cited by 13
Cited by
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Abeshouse, A., Adebamowo, C., Adebamowo, S. N., Akbani, R., Akeredolu, T., Ally, A., Anderson, M. L., Anur, P., Appelbaum, E. L., Armenia, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.014 · Cited by 1,069
Self-citationLee, W., Teckie, S., Wiesner, T., Ran, L., Prieto Granada, C. N., Lin, M., Zhu, S., Cao, Z., Liang, Y., Sboner, A., et al. (2014) · Nature Genetics · doi:10.1038/ng.3095 · Cited by 619
Self-citationClinical implications of intratumor heterogeneity: challenges and opportunities
Ramón y Cajal, S., Sesé, M., Capdevila, C., Aasen, T., De Mattos-Arruda, L., Diaz-Cano, S. J., Hernández-Losa, J., & Castellví, J. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01874-2 · Cited by 514
Sarcoma treatment in the era of molecular medicine
Grünewald, T. G., Alonso, M., Avnet, S., Banito, A., Burdach, S., Cidre‐Aranaz, F., Di Pompo, G., Distel, M., Dorado‐Garcia, H., Garcia‐Castro, J., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911131 · Cited by 319
Hypoxia-Dependent Modification of Collagen Networks Promotes Sarcoma Metastasis
Eisinger-Mathason, T. S. K., Zhang, M., Qiu, Q., Skuli, N., Nakazawa, M. S., Karakasheva, T., Mucaj, V., Shay, J. E. S., Stangenberg, L., Sadri, N., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0118 · Cited by 277
Metadata
- Authors
- Taylor, B. S., Barretina, J., Maki, R. G., Antonescu, C. R., Singer, S., & Ladanyi, M.
- Venue
- Nature Reviews Cancer
- Published
- 2011-07-14
- Volume
- 11
- Issue
- 8
- Pages
- 541-557
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1988968354
- Cited by
- 427
- References
- 194
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.